Vasoconstrictive properties of the 5HT1B/1D agonists:: response to Dahlof and Mathew

被引：0

作者：

Goldstein, D ^{[1
]}

机构：

[1] Lilly Corp Ctr, Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

CEPHALALGIA | 1999年 / 19卷 / 05期

关键词：

D O I：

10.1177/033310249901900503

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：536 / 536

页数：1

共 50 条

[31] Only 5HT1B/1D agonist doses of 4991W93 inhibit CGRP release in the cat.
Knight, YE
Connor, HE
Edvinsson, L
Goadsby, PJ
CEPHALALGIA, 1999, 19 (04) : 401 - 402
[32] Serotonin 5HT1B/1D receptor agonists abolish NMDA receptor-evoked enhancement of nitric oxide synthase activity and cGMP concentration in brain cortex slices
Stepien, A
Chalimoniuk, M
Strosznajder, J
CEPHALALGIA, 1999, 19 (10) : 859 - 865
[33] 5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists:: Potential treatments for migraine
Meng, CQ
Rakhit, S
Lee, DKH
Kambo, R
McCallum, KL
Mazzocco, L
Dyne, K
Slassi, A
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2000, 10 (09) : 903 - 905
[34] Frovatriptan -: Antimigraine 5-HT1B/1D agonist
不详
DRUGS OF THE FUTURE, 2001, 26 (07) : 705 - 706
[35] Mechanisms of action of serotonin 5-HT1B/1D agonists:: Insights into migraine pathophysiology using rizatriptan
Goadsby, PJ
Hargreaves, RJ
NEUROLOGY, 2000, 55 (09) : S8 - S14
[36] Serotonin 5-HT1B/1D receptor agonists in migraine -: Comparative pharmacology and its therapeutic implications
Goadsby, PJ
CNS DRUGS, 1998, 10 (04) : 271 - 286
[37] Consequences of transforming measures of efficacy for acute therapies:: 5-HT1B/1D agonists as a worked example
Fox, AW
Keywood, C
Sheftell, FD
Spierings, ELH
HEADACHE, 2004, 44 (01): : 48 - 52
[38] Profiles of 5-HT1B/1D agonists in acute migraine with special reference to second generation agents
Deleu, D
Hanssens, Y
ACTA NEUROLOGICA BELGICA, 1999, 99 (02) : 85 - 95
[39] New aniline derivatives as key intermediates in the synthesis of 5-HT1B/1D receptor agonists - 41253
Fernandez-Forner, D.
Research Disclosure, 1998, (412):
[40] Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor:: A central action in migraine?
Goadsby, PJ
Hoskin, KL
ANNALS OF NEUROLOGY, 1998, 43 (06) : 711 - 718

← 1 2 3 4 5 →